CASRN: 22204-24-6
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of pyrantel pamoate during breastfeeding. It is poorly absorbed orally, so excretion into breastmilk and absorption by the breastfed infant is unlikely.[1]
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
- 1.
- Porto I. Antiparasitic drugs and lactation: Focus on anthelmintics, scabicides, and pediculicides. J Hum Lact. 2003;19:421–5. [PubMed: 14620457]
Substance Identification
Substance Name
Pyrantel
CAS Registry Number
22204-24-6
Drug Class
Breast Feeding
Lactation
Antinematodal Agents
Antiparasitic Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
Publication Details
Publication History
Last Revision: May 17, 2021.
Copyright
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Publisher
National Institute of Child Health and Human Development, Bethesda (MD)
NLM Citation
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-. Pyrantel. [Updated 2021 May 17].